Drug Profile
Research programme: erectile dysfunction therapies - Amilar Pharmaceuticals
Alternative Names: BIO037; Erectile dysfunction therapies research programme - Amilar PharmaceuticalsLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Amilar Pharmaceuticals
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Erectile dysfunction
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Erectile-dysfunction in USA
- 06 Oct 2005 Preclinical trials in Erectile dysfunction in USA (unspecified route)